136th Day Of Lockdown

Maharashtra47977931637516792 Tamil Nadu2791442210874571 Andhra Pradesh1967891128701753 Karnataka158254802812897 Delhi1415311271244059 Uttar Pradesh108974634021918 West Bengal86754610231902 Telangana7525753239601 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
Lifestyle Health and Wellbeing 05 Mar 2018 New strategies for t ...

New strategies for treating opioid addiction

ANI
Published Mar 5, 2018, 9:04 pm IST
Updated Mar 5, 2018, 9:04 pm IST
Opioid use disorder is often a chronic, relapsing condition associated with increased morbidity and risk of death.
There is an urgent need for health systems to look at the historical gaps and invest in providing timely and evidence-based treatment. (Photo: Pixabay)
 There is an urgent need for health systems to look at the historical gaps and invest in providing timely and evidence-based treatment. (Photo: Pixabay)

The new Canadian guidelines for managing opioid use disorders, have laid out the optimal strategies for the treatment of opioid addiction, including recommending opioid against treatment with buprenorphine-naloxone as the preferred first-line treatment.

The guideline was created for a wide range of health care providers to address an urgent need for evidence-based treatment of opioid use causing overdoses and death.

 

"Opioid use disorder is a public health emergency nationwide and this guideline provides a blueprint for health practitioners to step up and provide evidence-based care," says Dr. Julie Bruneau lead author of the pan-Canadian guideline group.

In 2016, the rate of opioid-related deaths in Canada was 7.9 per 100 000 (a total of 2861 deaths), and the number of deaths continues to increase.

The opioid epidemic affecting both Canada and the United States is fuelled by a combination of overprescribing as well as the influx of highly potent illegal synthetic opioids, such as illicitly manufactured fentanyl.

 

"Traditionally, resources for the treatment of opioid addiction have been scarce, and guidelines outlining best practices and practices to avoid have been lacking," said Dr. Evan Wood, senior author.

To address the traditional gaps in knowledge in this area, the guideline aimed to provide Canadian health care professionals and health authorities with national clinical practice recommendations for treating opioid use disorder.

The review panel included 43 health care practitioners with broad experience who are part of the Canadian Institutes of Health Research's Canadian Research Initiative in Substance Misuse (CRISM). The guideline group also involved people with opioid use disorder experience, and considered patient values and preferences in developing its recommendations.

 

Key recommendations:

- Start opioid agonist treatment with buprenorphine-naloxone whenever possible to reduce risk of toxicity, illness and death

- In people who respond poorly to buprenorphine-naloxone, consider transitioning to methadone treatment

- Start opioid agonist treatment with methadone when buprenorphine-naloxone is not the preferred option

- In people who respond well to methadone and who want simpler treatment, consider transitioning to buprenorphine-naloxone

- In patients who do not respond to the above therapies, consider slow-release oral morphine, prescribed as daily witnessed doses

 

- Avoid withdrawal management alone without transition to long-term treatment to reduce risk of relapse and death.

Beyond recommending best practices, like the use of buprenorphine-naloxone as first-line treatment whenever possible, the guideline also identified how certain common practices in the Canadian health care system should be avoided - specifically, how offering withdrawal management as an isolated strategy for the treatment of opioid use disorder actually increases rates of overdose.

"With these recommendations laid out, there is an urgent need for health systems to look at the historical gaps in care and invest in providing timely and evidence-based treatment," said Dr. Bruneau.

 

"By encouraging physicians to work alongside their patients to identify the safest, most effective approach first, these new guidelines ensure the best science and evidence are integrated into care", Dr. Bruneau continued.

Opioid use disorder is often a chronic, relapsing condition associated with increased morbidity and risk of death. However, with appropriate treatment and follow-up, individuals can reach sustained long-term remission.

The findings from the study are published in the journal Canadian Medical Association Journal.

 

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT